MetaCap

Alpha Tau Medical Ltd. Company Profile

NASDAQ: DRTSHealth CareMedical/Dental InstrumentsUSD

13.73-0.52 (-3.65%)

Market open · Delayed 15 min · as of Oct 8, 10:13 AM ET

Alpha Tau Medical at a glance

Alpha Tau Medical Ltd. (NASDAQ: DRTS) is a Medical/Dental Instruments company in the Health Care sector headquartered in Jerusalem, Israel. Alpha Tau Medical is led by Mr. Uzi Sofer and employs about 121 people. At a market capitalization of $1.34 billion, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001871321, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Alpha Tau Medical do?

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Business description based on the company's public filings.

Company information

Legal name
Alpha Tau Medical Ltd.
Ticker
NASDAQ: DRTS
Industry
Medical/Dental Instruments
CEO
Mr. Uzi Sofer
Employees
121
Headquarters
Kiryat HaMada St. 5, Jerusalem, Israel
Phone
972 3 577 4115
SEC CIK
0001871321

Companies similar to Alpha Tau Medical

DRTS peer companies
CompanyPrice% ChgMarket capCompare
KMTSKestra Medical Technologies Ltd.25.79-2.64%$1.54Bvs DRTS
ATECAlphatec Holdings Inc.10.20-0.49%$1.58Bvs DRTS
IRMDiRadimed Corporation84.98-0.57%$1.09Bvs DRTS
TNDMTandem Diabetes Care Inc.15.31-3.35%$1.07Bvs DRTS
AORTArtivion Inc.21.29-1.50%$1.04Bvs DRTS
IARTIntegra LifeSciences Holdings Corporation13.11+0.85%$1.02Bvs DRTS
NVCRNovoCure Limited14.37-1.98%$1.67Bvs DRTS
PRCTPROCEPT BioRobotics Corporation17.62-1.62%$1.00Bvs DRTS

Related